Thank you
This live web event has ended. Thank you for attending.
Description
Immunotherapy for non-melanoma skin cancer" will use real-world cases to discuss the role of immunotherapy in the treatment of non-melanoma skin cancer.
Contributors
-
Abigail H. Waldman, MD
Dr. Abigail Waldman is currently a Board Certified Dermatologist and the Director of the Mohs and Dermatologic Surgery Center, as well as the Director of Mohs Surgery at the VA Boston Healthcare System. She is also an Assistant Professor at Harvard Medical School. She completed Medical School at Yale University School of Medicine, then completed her Residency at Yale New Haven Hospital in 2015.
-
Emily S. Ruiz, MD, MPH
Dr. Emily Ruiz is currently a Board Certified Dermatologist and the Academic Director of the Mohs and Dermatologic Surgery Center, as well as the Director of the High-Risk Skin Cancer Clinic at the Dana-Farber Brigham Cancer Center. She is also an Assistant Professor at Harvard Medical School. She completed Medical School at New York University School of Medicine, then completed her Residency at Albert Einstein College of Medicine in 2014.